Trial · NCT00414973

Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Teriparatide - Females	218
Overall Study	STARTED	Calcitonin - Females	109
Overall Study	STARTED	Teriparatide - Males	24
Overall Study	STARTED	Calcitonin - Males	11
Overall Study	COMPLETED	Teriparatide - Females	190
Overall Study	COMPLETED	Calcitonin - Females	99
Overall Study	COMPLETED	Teriparatide - Males	21
Overall Study	COMPLETED	Calcitonin - Males	11
Overall Study	NOT COMPLETED	Teriparatide - Females	28
Overall Study	NOT COMPLETED	Calcitonin - Females	10
Overall Study	NOT COMPLETED	Teriparatide - Males	3
Overall Study	NOT COMPLETED	Calcitonin - Males	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00414973/flow